Association of interleukin 8 and myocardial recovery in patients with ST-elevation myocardial infarction complicated by acute heart failure.

Autor: Trygve Husebye, Jan Eritsland, Harald Arnesen, Reidar Bjørnerheim, Arild Mangschau, Ingebjørg Seljeflot, Geir Øystein Andersen

Publikováno v: PLoS ONE, Vol 9, Iss 11, p e112359 (2014)

No data from controlled trials exists regarding the inflammatory response in patients with de novo heart failure (HF) complicating ST-elevation myocardial infarction (STEMI) and a possible role in the recovery of contractile function. We therefore ex

Externí odkaz: https://doaj.org/article/b710ad11519c47918e7da07564ba9e74

Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock

Autor: Guro Grindheim, Ingebjørg Seljeflot, Søren Erik Pischke, Tom Eirik Mollnes, Peter Garred, Geir Øystein Andersen, Arne Yndestad, Trygve Husebye, Hilde Lang Orrem, Per H. Nilsson, Pål Aukrust, Andreas Barratt-Due

Publikováno v: ESC Heart Failure. 5:292-301

AIMS Heart failure (HF) is an impending complication to myocardial infarction. We hypothesized that the degree of complement activation reflects severity of HF following acute myocardial infarction. METHODS AND RESULTS The LEAF trial (LEvosimendan in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::88f256a0669858f55a1fb936015096e1
https://doi.org/10.1002/ehf2.12266

Short-Term Therapies for Treatment of Acute and Advanced Heart Failure—Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?

Autor: Leo M. A. Heunks, Mehmet Yilmaz, Cândida Fonseca, Gerhard Pölzl, Bojan Vrtovec, Pentti Põder, Tuvia Ben Gal, Alexandre Mebazaa, Alexander Parkhomenko, John Parissis, Sundeep Kaul, Alexandr A. Eremenko, Jacek Kubica, Visnja Ivancan, Trygve Husebye, Josep Comín-Colet, Matthias Heringlake, Vladimir Cerny, Zoltán Papp, Dimitrios Farmakis, Antoine Herpain, Veli-Pekka Harjola, Dominique Bettex, Henning Mølgaard, Piero Pollesello, Kristian Karason, Francesco Fedele

Publikováno v: Pollesello, P, Ben Gal, T, Bettex, D, Cerny, V, Comin-Colet, J, Eremenko, A A, Farmakis, D, Fedele, F, Fonseca, C, Harjola, V-P, Herpain, A, Heringlake, M, Heunks, L, Husebye, T, Ivancan, V, Karason, K, Kaul, S, Kubica, J, Mebazaa, A, Mølgaard, H, Parissis, J, Parkhomenko, A, Põder, P, Pölzl, G, Vrtovec, B, Yilmaz, M B & Papp, Z 2019, ' Short-Term Therapies for Treatment of Acute and Advanced Heart Failure—Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline? ', Journal of Clinical Medicine, vol. 8, no. 11, pp. 1834 . https://doi.org/10.3390/jcm8111834
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 8, Iss 11, p 1834 (2019)
Journal of Clinical Medicine, 8 (11
Journal of Clinical Medicine, 8(11)

Both acute and advanced heart failure are an increasing threat in term of survival, quality of life and socio-economical burdens. Paradoxically, the use of successful treatments for chronic heart failure can prolong life but—per definition—causes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1115eae774dfeaf4f19b909731027841
https://research.vumc.nl/en/publications/883653d9-408b-44de-a05e-141356184d55

Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction

Autor: Geir Øystein Andersen, Pavel Hoffmann, Tom Eirik Mollnes, Jan Eritsland, Arne Yndestad, Hilde Lang Orrem, Christian Shetelig, Trygve Husebye, Shanmuganathan Limalanathan, Per H. Nilsson, Thor Ueland, Pål Aukrust, Ingebjørg Seljeflot

Publikováno v: International Journal of Cardiology

Accepted manuscript version. Published version available at https://doi.org/10.1016/j.ijcard.2018.05.032. Licensed CC BY-NC-ND 4.0. Background: The inflammatory response following myocardial infarction (MI) is prerequisite for proper healing of infar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c521720552edb2d265e6894082ce5cb
http://hdl.handle.net/11250/2603747

Levosimendan in acute heart failure following primary percutaneous coronary intervention‐treated acute ST‐elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo‐controlled study

Autor: Trygve Husebye, Ingebjørg Seljeflot, Harald Arnesen, Leiv Sandvik, Jan Eritsland, Geir Øystein Andersen, Carl Müller, Reidar Bjørnerheim, Arild Mangschau

Publikováno v: European Journal of Heart Failure. 15:565-572

Aims The calcium sensitizer levosimendan may counteract stunning after reperfusion of ischaemic myocardium, but no randomized placebo-controlled trials exist regarding its use in PCI-treated ST-segment elevation infarction (STEMI). We evaluated the e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e71ece3a0d3a53618db3fa20a8fe457c
https://doi.org/10.1093/eurjhf/hfs215